Quantbot Technologies LP Viking Therapeutics, Inc. Transaction History

Quantbot Technologies LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$47.39 - $80.2 $237,613 - $402,122	5,014 Added 1340.64%	5,388 $285,000
Q1 2024 May 06, 2024	BUY	$17.4 - $94.5 $6,507 - $35,343	374 New	374 $30,000
Q4 2021 Feb 11, 2022	SELL	$4.6 - $6.72 $919 - $1,344	-200 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$5.58 - $7.04 $1,116 - $1,408	200 New	200 $1,000
Q1 2020 May 13, 2020	SELL	$3.45 - $7.95 $690 - $1,590	-200 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$6.38 - $8.73 $1,276 - $1,746	200 New	200 $1,000
Q4 2018 Feb 13, 2019	SELL	$7.16 - $16.21 $44,993 - $101,863	-6,284 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$9.7 - $19.65 $60,954 - $123,480	6,284 New	6,284 $109,000

476

63.4M

5.76M

3.39M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $2.5B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.